Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)
China · Delayed Price · Currency is CNY 88.83
-3.12 (-3.39%)
Sep 4, 2026, 3:00 PM CST
SHA:688131 Market Cap
SHA:688131 has a market cap or net worth of 18.94 billion as of September 4, 2026. Its market cap has increased by 26.69% in one year.
Market Cap
18.94B
Enterprise Value
19.76B
Revenue
3.21B
Ranking
n/a
PE Ratio
72.82
Stock Price
88.83
ChartMarket Cap Chart
Since June 8, 2021, SHA:688131's market cap has decreased from 23.30B to 18.94B, a decrease of -18.71%. That is a compound annual growth rate of -3.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 18.94B | 23.89% |
| Dec 31, 2025 | 15.29B | 103.03% |
| Dec 31, 2024 | 7.53B | -3.82% |
| Dec 29, 2023 | 7.83B | -32.18% |
| Dec 30, 2022 | 11.54B | -37.56% |
| Dec 31, 2021 | 18.49B | -20.66% |
| Jun 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jilin Aodong Pharmaceutical Group | 21.68B |
| Livzon Pharmaceutical Group | 20.97B |
| Guangdong Zhongsheng Pharmaceutical | 20.94B |
| Walvax Biotechnology | 20.76B |
| Betta Pharmaceuticals | 20.61B |
| Hybio Pharmaceutical | 20.16B |
| Harbin Pharmaceutical Group | 19.59B |
| Kangmei Pharmaceutical | 19.08B |